NYSEHealth CareHealth Care FacilitiesS&P SmallCap 600
$99.49
+2.29 (+2.36%)
Close of Nov 06, 2026 · end-of-day data
USPH 8-K filings in 2024
Every material Form 8-K U.S. Physical Therapy filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On October 31, 2024, U.S. Physical Therapy completed its acquisition of a 50% interest in MSO Metro, LLC, which manages 50 outpatient physical therapy clinics, mostly in New York. The company also became Metro's managing member and expanded its board from seven to eight directors, adding Metro CEO Michael G. Mayrsohn; the filing gives an effective date of February 24, 2025 for that appointment.
Purchase price was approximately $76.5 million: $75 million in cash on hand and $1.5 million paid through 18,358 newly issued common shares.
Sellers can earn up to another $20.0 million if certain Metro performance criteria are met.
Through its managed therapy providers, Metro currently generates approximately $64.0 million in annual revenue and $12.0 million in annual EBITDA.
Michael G. Mayrsohn, Metro's CEO since 2016, was appointed a director and will serve until the 2025 annual meeting.
U.S. Physical Therapy's subsidiary agreed to acquire a 50% interest in MSO Metro, LLC, which manages 50 outpatient clinics, mostly in New York, and will make the company its managing member. The purchase price is approximately $76.5 million, with $75 million from cash on hand and $1.5 million in company stock, plus an earnout of up to $20.0 million if performance criteria are met. The deal is expected to close on October 31, 2024, subject to customary closing conditions.
Purchase price of approximately $76.5 million: $75 million in cash on hand and $1.5 million in common stock
Earnout of up to an additional $20.0 million if certain Metro performance criteria are achieved
Metro generates approximately $64.0 million in annual revenue and $12.0 million in annual EBITDA, per the press release
Expected closing date of October 31, 2024; the company will become managing member of Metro
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every U.S. Physical Therapy filing is on SEC EDGAR ↗. 8-K briefs of other companies →